Breast magnetic resonance imaging in patients with occult breast carcinoma: Evaluation on feasibility and correlation with histopathological findings

Chinese Medical Journal

Volumn 124, Issue 12, 2011, Pages 1790-1795

  Lu, Hong ^a   Xu, Yi Lin ^a   Zhang, Shu Ping ^a   Lang, Rong Gang ^a   Zee, Chi S ^b   Liu, Pei Fang ^a   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breast cancer; Histopathology; Magnetic resonance imaging; Occult primary breast carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST LESION; CANCER GRADING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; GLYCOGEN RICH CLEAR CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; INVASIVE MICROPAPILLARY CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PRIMARY TUMOR; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; BREAST; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79959507496     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999     Document Type: Article

References (27)

1. Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 6: 1-19.
2. de Bresser J, de Vos B, van der Ent F, Hulsewé K. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 2010; 36: 114-119.
3. Jackson VP. The role of US in breast imaging. Radiology 1990; 177: 305-311.
4. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 75-89.
5. Wang SM. Concerns on diagnosis and treatment of breast cancer in China. Chin Med J 2007; 120: 1741-1742.
6. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Imaging 2003; 17: 509-520.
7. Schnall MD, Ikeda DM. Lesion diagnosis working group report. J Magn Reson Imaging 1999; 10: 982-990.
8. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002; 41: 151-152.
9. Wang X, Zhao Y, Cao X. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases. Breast J 2010; 16: 32-37.
10. Lieberman S, Sella T, Maly B, Sosna J, Uziely B, Sklair-Levy M. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma. Isr Med Assoc J 2008; 10: 448-452.
11. Ko EY, Han BK, Shin JH, Kang SS. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007; 8: 382-389.
12. Bartella L, Liberman L, Morris EA, Dershaw DD. Nonpalpable ammographically occult invasive breast cancers detected by MRI. AJR Am J Roentgenol 2006; 186: 865-870.
13. Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003; 181: 619-626.
14. Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005; 12: 1045-1053.
15. Olson JA Jr, Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000; 7: 411-415.
16. Daniel BL, Gardner RW, Birdwell RL, Nowels KW, Johnson D. Magnetic resonance imaging of intraductal papilloma of the breast. Magn Reson Imaging 2003; 21: 887-892.
17. Abe H, Schmidt RA, Shah RN, Shimauchi A, Kulkarni K, Sennett CA, et al. MR-directed ("second-look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic Findings. AJR Am J Roentgenol 2010; 194:370-377.
18. Lehman CD, Deperi ER, Peacock S, McDonough MD, Demartini WB, Shook J. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol 2005; 184: 1782-1787.
19. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: 830-849.
20. Zujewski J, Eng-Wong J. Sentinel lymph node biopsy in the management of ductal carcinoma in situ. Clin Breast Cancer 2005; 6: 216-222.
21. Schelfout K, Kersschot E, Van Goethem M, Thienpont L, Van den Haute J, Roelstraete A, et al. Breast MR imaging in a patient with unilateral axillary lymphadenopathy and unknown primary malignancy. Eur Radiol 2003; 13: 2128-2132.
22. Kaufmann O, Deidesheimer T, Muehlenberg M, Deicke P, Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology 1996; 29: 233-240.
23. Obdeijn IM, Brouwers-Kuyper EM, Tilanus-Linthorst MM, Wiggers T, Oudkerk M. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol 2000; 174: 1079-1084.
24. Pentheroudakis G, Lazaridis G, Pavlidis N. Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. Breast Cancer Res Treat 2010; 119: 1-11.
25. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple-negative early-stage breast cancer. J Clin Oncol 2006; 24: 5652-5657.
26. Chen JH, Agrawal G, Feig B, Baek HM, Carpenter PM, Mehta RS, et al. Triple-negative breast cancer: MRI features in 29 patients. Ann Oncol 2007; 18: 2042-2043.
27. Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 2009; 250: 638-647.